Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome.
BACKGROUND
Irritable bowel syndrome (IBS), which affects 11% to 14% of the population, is a puzzling condition with multiple models of pathophysiology including altered motility, visceral hypersensitivity, abnormal brain-gut interaction, autonomic dysfunction, and immune activation. Although no conceptual framework accounts for all the symptoms and observations in IBS, a unifying explanation may exist since 92% of these patients share the symptom of bloating regardless of their predominant complaint.


METHODS
Ovid MEDLINE was searched through May 2004 for relevant English-language articles beginning with those related to bloating, gas, and IBS. Bibliographies of pertinent articles and books were also scanned for additional suitable citations.


RESULTS
The possibility that small intestinal bacterial overgrowth (SIBO) may explain bloating in IBS is supported by greater total hydrogen excretion after lactulose ingestion, a correlation between the pattern of bowel movement and the type of excreted gas, a prevalence of abnormal lactulose breath test in 84% of IBS patients, and a 75% improvement of IBS symptoms after eradication of SIBO. Altered gastrointestinal motility and sensation, changed activity of the central nervous system, and increased sympathetic drive and immune activation may be understood as consequences of the host response to SIBO.


CONCLUSIONS
The gastrointestinal and immune effects of SIBO provide a possible unifying framework for understanding frequent observations in IBS, including postprandial bloating and distension, altered motility, visceral hypersensitivity, abnormal brain-gut interaction, autonomic dysfunction, and immune activation.
Division of Gastrointestinal and Liver Diseases, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles 90033, USA. henry.c.lin@usc.edu
Henry C
HC
Lin
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D018407:Bacterial Physiological Phenomena; D003248:Constipation; D005285:Fermentation; D005356:Fibromyalgia / Q000382:microbiology / Q000503:physiopathology; D005740:Gases; D005769:Gastrointestinal Motility; D006801:Humans; D007249:Inflammation; D007421:Intestine, Small / Q000382:microbiology* / Q000502:physiology*; D043183:Irritable Bowel Syndrome / Q000175:diagnosis / Q000382:microbiology* / Q000503:physiopathology*
D000900:Anti-Bacterial Agents; D005740:Gases